Genzyme Agrees to Sell Pharmaceuticals Unit to Chemical Group

Genzyme Corpo. said that it has completed the sale of its diagnostic products business to Sekisui Chemical Co. Ltd. for $265 million in cash.

To contact the editor responsible for this story: Steven Fromm at sfromm@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.